These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 204532)

  • 1. Abrogation of BCG-contact induced tumour inhibition by silica: implications for the mechanism of action.
    Moore M; Nisbet NW
    Dev Biol Stand; 1977 Apr 13-15; 38():233-9. PubMed ID: 204532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of transplanted sarcomas mediated by BCG in rats with a defined immunological deficit.
    Moore M; Lawrence N; Nisbet NW
    Biomedicine; 1976 Jan; 24(1):26-31. PubMed ID: 773443
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Host responses in adjuvant contact suppression of experimental rat tumours.
    Pimm MV; Hopper DG; Baldwin RW
    Dev Biol Stand; 1977 Apr 13-15; 38():349-54. PubMed ID: 344098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumour inhibition mediated by BCG in immunosuppressed rats.
    Moore M; Lawrence N; Nisbet NW
    Int J Cancer; 1975 Jun; 15(6):897-911. PubMed ID: 1150345
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of silica on the anti-tumour activity of "Corynebacterium parvum" (author's transl)].
    Mazurek C; Stiffel C; Chalvet H; Biozzi G
    Ann Immunol (Paris); 1979; 130(6):815-26. PubMed ID: 232975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of silica and fly ash dust inhalation on alveolar macrophage effector cell function.
    Burns CA; Zarkower A
    J Reticuloendothel Soc; 1982 Dec; 32(6):449-59. PubMed ID: 6298411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abrogation of antitumor effects of Corynebacterium parvum and BCG by antimacrophage agents: brief communication.
    Keller R
    J Natl Cancer Inst; 1977 Dec; 59(6):1751-3. PubMed ID: 200763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Reaction of pulmonary macrophages activated by BCG to silica. II. A study of the changes of the permeability of lysosomal membrane].
    Li WD
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1982 Aug; 5(4):239-42. PubMed ID: 6293785
    [No Abstract]   [Full Text] [Related]  

  • 9. [Cytotoxic effect of BCG-activated macrophages on tumor target cells in vitro].
    Viadro MM
    Biull Eksp Biol Med; 1979 Jan; 87(1):36-9. PubMed ID: 760842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumor cytokinetics in the presence of normal, alloimmune, or Bacillus Calmette-Guérin-activated host cells simultaneously assayed in vivo and in vitro.
    Normann SJ; Cornelius J
    Cancer Res; 1987 Apr; 47(8):2067-72. PubMed ID: 3828996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of either rapidly cytolytic macrophages or NK cells in "activated" peritoneal exudates depends on the method of analysis and the target cell type.
    Gray JD; Brooks CG; Baldwin RW
    Immunology; 1981 Apr; 42(4):561-8. PubMed ID: 6263794
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific passive immunotherapy of experimental lymphoma. Effects of macrophage toxic drugs.
    Gerlier D; Avice T; Doré JF
    Biomedicine; 1979 Jul; 31(4):106-10. PubMed ID: 226195
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Macrophages and resistance to tumours: influence of agents affecting macrophages and delayed-type hypersensitivity on resistance to tumours inducing concomitant immunity.
    Nelson M; Nelson DS
    Aust J Exp Biol Med Sci; 1978 Apr; 56(2):211-23. PubMed ID: 209776
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phagocytosis of Mycobacterium bovis BCG organisms by murine S180 sarcoma cells.
    Devadoss PO; Klegerman ME; Groves MJ
    Cytobios; 1993; 74(296):49-58. PubMed ID: 8330487
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effector mechanism in antitumor activity of monoclonal antibodies produced against an ascitic mouse mammary tumor.
    Seto M; Takahashi T; Nakamura S; Saito M; Hara T; Nishizuka Y
    Cancer Res; 1986 Apr; 46(4 Pt 2):2056-61. PubMed ID: 3004718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Host responses with solid tumors. I. Monocytic effector cells within rat sarcomas.
    Haskill JS; Proctor JW; Yamamura Y
    J Natl Cancer Inst; 1975 Feb; 54(2):387-93. PubMed ID: 1113322
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrophages and tumours.
    Alexander P
    Schweiz Med Wochenschr; 1976 Oct; 106(40):1345-50. PubMed ID: 1006251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The binding of BCG-activated macrophages to tumor targets stimulates secretion of cytolytic factor.
    Johnson WJ; Whisnant CC; Adams DO
    J Immunol; 1981 Nov; 127(5):1787-92. PubMed ID: 6795261
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of BCG and cyclophosphamide on the antitumor activity of mouse peritoneal macrophages].
    Gromov SA; Okulov VB; Voĭtenkov BO
    Eksp Onkol; 1989; 11(3):63-6. PubMed ID: 2752946
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Induction of activated macrophages by intraperitoneal injection of mitomycin C in mice and rats].
    Ogura T
    Gan To Kagaku Ryoho; 1986 Mar; 13(3 Pt 2):689-96. PubMed ID: 3083782
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.